Decline of life’s energy theory of ageing 2. Restoration of anabolic and regulatory processes

Bibliography

• BERGHE GV: Novel insights into the neuroendocri-nology of critical illness. Eur. j Endocrinol (2000) 143(0:1–13.
   PubMedGoogle Scholar
• BROSS R, STORER T, BHASIN S: Aging and muscle loss. (1999) 10 (5) :194–198.
   Google Scholar
• CALLES-ESCANDON J, POEHLMAN ET: Aging, fat oxidation and exercise. Ageing (Milano) (1997) 9(1-2):57–63.
   PubMedGoogle Scholar
• BEMBEN MG, MASSEY BH, BEMBEN DA et al.: Age-related patterns in body composition for men aged 20-79 yr. Med. Sci. Sports Exerc. (1999) 27(2):264–269.
   Google Scholar
• GARTHWAITE SM, CHENG H, BRYAN JE et al: Aging, exercise and food restriction: effects on body composition. Mech. Ageing Dev. (1986) 3 6 (2):187–196.
   Google Scholar
• TOTH MJ, BECKETT T, POEHLMAN E: Physical activity and the progressive change in body composition with ageing: current evidence and research issues. MED. Sci Sports Exerc. (1999) 31 (Suppl. 11):S590–S596.
   Google Scholar
• KEHAYIAS JJ, FIATARONE MA, ZHUANG H et al: Total body potassium and body fat: relevance to aging. Am]. Nutr. (1997) 6 6 (4) :904–910.
   Google Scholar
• TREMOLLIERES FA, POUILLES JM, RIBOT CA: Relative influence of age and menopause on total and regional body composition changes in postmenopausal women. Am. J. Obstet. Gynecol (1996) 175 (6) :1594–600.
   PubMed Web of Science ®Google Scholar
• BOTTIGER LE: Regular decline in physical working capacity with age. Br. J. Med. (1973) 3:270–271.
   PubMed Web of Science ®Google Scholar
• MOORE DH: A study of age group track and field records to relate age and running speed. Nature (1975) 253:264–265.
   PubMed Web of Science ®Google Scholar
• RIEGEL PS: Athletic records and human endurance. Am. Sci. (1981) 69:285–290.
   PubMed Web of Science ®Google Scholar
• ANDERSON RN: United States life tables 1997. National Vital Statistics Report. CDC (1999) 47(28).
   Google Scholar
• SHORT KR, NAIR KS: Mechanisms of sarcopenia of aging. J. Endocrin. Invest. (1999) 22:95–105.
   PubMedGoogle Scholar
• PIEGELSON W, COLMAN C: The super hormone promise. Pocket Books, Simon and Schuster, Inc., NY. (1996)7, 206.
   Google Scholar
• PIERPAOLI W: Neuroimmunomodulation of aging. A program in the pineal gland. Ann. NY. Acad. Sci. (1997) 774:491–497.
   Google Scholar
• GARTHWAITE SM, CHENG H, BRYAN JE et al.: Aging,exercise and food restriction: effects on body composition. Mech. Ageing Dev. (1986) 3 6 (2):187–196.
   Google Scholar
• TOTH MJ, BECKETT T, POEHLMAN ET: Physical activityand the progressive change in body composition with aging: current evidence and research issues. Med. Sci. Sports Exerc. (1999) 32 (Suppl. 11):S590–S596.
   Google Scholar
• TREMOLLIERES FA, POUILLES JM, RIBOT CA: Relativeinfluence of age and menopause on total and regional body composition changes in postmenopausal women. Am. J. Obstet. Gynecol. (1996) 175 (6):1594–1600.
   PubMed Web of Science ®Google Scholar
• ZADIK Z CHALEW SA, MCCARTER RJ et al: The influence of age on the 24 hour integrated concentration of growth hormone in normal individuals. J. Clin. Endocrinol. Met. (1985) 60(3):513–516.
   PubMedGoogle Scholar
• BUTTGEREIT F, BRAND MD: A hierarchy of ATP-consuming processes in Mammalian Cells. Biochem. J. (1995) 321:163–167.
   Google Scholar
• YEN T-C, CHEN Y-S, KING K-L et al.: liver mitochondrialrespiratory functions decline with age. Biochem. Biophys. Res. Commun. (1989) 165:994–1003.
   Google Scholar
• MCCAY CM, CROWELL MF, MAYNARD LA: The effect of retarded growth upon the length oflife-span and upon the ultimate body size. J Nutr. (1935), Nutrition (1989) 5:155-171 Discussion 172.
   Google Scholar
• ••The original calorie restriction experiments.
   Google Scholar
• PARADIES G, RUGGIERO FM, GADALETA MN et al.: The effect of aging and acetyl-L-carnitine on the activity of the phosphate carrier and on the phsopholipid composition in rat heart mitochondria. Biochim. Biophys. Acta (1992) 1103:324–326.
   PubMed Web of Science ®Google Scholar
• PARR T: Insulin exposure controls the rate of mammalian aging. Mech. Aging Dev. (1996) 88:75–82.
   PubMed Web of Science ®Google Scholar
• PARR T: Insulin exposure and aging theory. Gerontology (1997) 43:182–200.
   PubMed Web of Science ®Google Scholar
• PARR T: Insulin exposure and unifying aging. Gerontology (1999) 45:121–135.
   PubMed Web of Science ®Google Scholar
• ••The most comprehensive explanation of calorie restriction.
   Google Scholar
• CZECH MP, KLARLUND JK, YAGALOF KA et al.: Insulinreceptor signaling. J. Biol. Chem. (1988) 263:11017–11020.
   PubMedGoogle Scholar
• SMITH RG, FEIGHNER S, PRENDERGAST K et al.: A neworphan receptor involved in pulsatile growth hormone release. Trends Endocrinol. Metabol. (1999) 10:128–135.
   PubMed Web of Science ®Google Scholar
• HOCH FL: Cardiolipins and biomembrane function.Biochim. Biophys. Acta (1992) 11 1 3:71–133.
   Google Scholar
• VALE W, BRAZEAU P, GRANT G et al.: Premieres observa-tions de la somatostatine, une facteur hypotha-lamique. CR Acad. Sci. Paris (1975) 275(D):2913.
   Google Scholar
• KOJIMA M, HOSADA H, DATE Y et al.: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. (1999) Nature 402:656–660.
   Google Scholar
• •The original discovery of a new GH secretagogue.
   Google Scholar
• DIEGUEZ C, CASANUEVA F: Ghrelin: a step forward in the understanding of somatotroph cell function and growth regulation. Eur. J. Endocrinol. (2000) 142 (5):413–417.
   PubMedGoogle Scholar
• HOSODA H, KOJIMA M, MATSUO H et al.: Purification and characterization of rat des-G1n14-ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor. J. Biol. Chem. (2000) 275 (29):21995–22000.
   PubMedGoogle Scholar
• REHFELD JF: Ghrelin - a new hormone. Ugeskr Laeger (2000) 162 (12):1751.
   PubMedGoogle Scholar
• CARRO E, SEOANE LM, SENARIS R et al.: lzptin increases in vivo GH responses to GHRH and GH-releasing peptide-6 in food-deprived rats. Eur. J. Endocrinol. (2000) 142 (1):66–70.
   PubMedGoogle Scholar
• RUDMAN D, FELLER AG, NAGRAJ HS et al: Effects of human growth hormone in men over 60 years old. New Engl. J. Med. (1990) 323 (1) :1–6.
   PubMed Web of Science ®Google Scholar
• •The documentation of the significance of GH replacement.
   Google Scholar
• POWRIE J, WEISSBERGER A, SONKSEN P: Growth hormone replacement therapy for growth hormone-deficient adults. Drugs (1995) 49(5):656–663.
   PubMedGoogle Scholar
• ROSEN T, JOHANNSSON G, JOHANSSON JO, BENGTSSONBA: Consequences of growth hormone deficiency in adults and the benefits and risks of recombinant human growth hormone treatment. Dorm. Res. (1995) 43:93–99.
   Google Scholar
• HOFFMAN, AR: Growth hormone therapy in the elderly: implications for the aging brain. Psychoneuro-Endocrinology (1992) 17 (4):327–333.
   PubMedGoogle Scholar
• GORDON CM, GLOWACKI J, LEBOFF MS: DHEA and the skeleton (through the ages). Endocrine (1999) 11(0:1–11.
   PubMedGoogle Scholar
• YEN SS, MORALES AJ, KHORRAM O: Replacement of DHEA in aging men and women. Potential remedial effects. Ann. NY Acad. Sci. (1995) 774:128–142.
   PubMed Web of Science ®Google Scholar
• •The documentation of the significance DHEA replacement.
   Google Scholar
• CHIU KM, SCHMIDT MJ, HAVIGHURST TC et al.: Correla-tion of serum L-carnitine and dehydroepiandros-terone sulphate levels with age and sex in healthy adults. Age Aging (1999) 28(2):211–216.
   PubMedGoogle Scholar
• YU B: Approaches to anti-aging intervention: the promises and the uncertainties. Mech. Aging Dev. (1999)111 (2-3):73–87.
   PubMedGoogle Scholar
• HINSON JP, RAVEN PW: DHEA deficiency syndrome: a new term for old age?j Endocrinol (1999) 163(1):1–5.
   PubMedGoogle Scholar
• MAZZA E, MACCARIO M, RAMUNNI J et al: Dehydroepi-androsterone sulfate levels in women. Relationships with age, body mass index and insulin levels. J. Endocrinol. Invest. (1999) 22 (9):681–687.
   Google Scholar
• PAOLISSO G, TAGLIAMONTE MR, RIZZO MR, GIUGLIANO D: Advancing age and insulin resistance: new facts about an ancient history. Eur. J. Clin. Invest. (1999) 29 (9):758–769.
   PubMedGoogle Scholar
• THOMAS N, MORRIS HA, SCOPACASA F et al.: Relation-ships between age, dehydro-epiandrosterone sulphate and plasma glucose in healthy men. AgeAging (1999) 28(2):217–220.
   Google Scholar
• MUKASA K, KANESIRO M, AOKI K et al.: Dehydroepian-dr o ster on e (DHEA) ameliorates the insulin sensitivity in older rats. J. Steroid Biochem. Mol. Biol. (1998) 67 (4):355–358.
   PubMedGoogle Scholar
• HADEN ST, GLOWACKI J, HURWITZ S et al.:Effects of ageon serum dehydroepiandrosterone sulfate, IGF-I and IL-6 levels in women. Calcif Tissue Int. (2000) 66 (6):414–418.
   PubMedGoogle Scholar
• BAULIEU EE, THOMAS G, LEGRAIN S et al.: Dehydroepi-androsterone (DHEA), DHEA sulfate and aging: contri-bution of the DHEAge Study to a sociobiomedical issue. Proc. Natl. Acad. Sci. USA (2000) 97 (8):4279–4284.
   PubMed Web of Science ®Google Scholar
• BELANGER A, CANDAS B, DUPONT A et al.: Serum concentrations of conjugated and unconjugated steroids in 40 to 80- year old men. J Clin. Endocrin. Metab. (1994) 79:1086–1090.
   PubMed Web of Science ®Google Scholar
• KATKOCIN DM, GUPTA K.M, COLLIPP PJ et al: Effects ofgrowth hormone on respiration and ATPase activity of rat liver and heart mitochondria. Biochem. Med (1979) 22:134–144.
   PubMed Web of Science ®Google Scholar
• MADDAIAH VT, SHARMA RK, BALACHANDAR V et al::Effect of growth hormone on mitochondrial protein synthesis. J Biol. Chem. (1973) 248:4263–4268.
   PubMed Web of Science ®Google Scholar
• •The significance of GH replacement at a cellular level.
   Google Scholar
• MADDAIAH VT, COLLIPP PJ, LIN JH et al.: Growth hormone and liver mitochondria effect on morphology and protein turnover. Biochem. Med. (1976) 16:47–54.
   PubMed Web of Science ®Google Scholar
• GRANT G, PARR T: Decline of life's energy theory of ageing. 1. revitalization of energy metabolism and ageing mitochondria. Exp. Opin. Ther. Patents (2000) 10 (8):1233–1243.
   Google Scholar
• ••The first DOLE theory paper.
   Google Scholar
• CLEJAN S, MADDAIAH VT: Growth hormone and liver mitochondria: effects on phospholipid composition and fatty acyl distribution. lipids (1986) 21:677–683.
   PubMedGoogle Scholar
• ZUMOFF B, STRAIN GW, KREAM J et al: Age variation of the 24-hour mean plasma concentrations of androgens, estrogens and gonadotropins in normal adult men. J. Clin. Endocrin. Met. (1992) 54:534–538.
   Google Scholar
• NANKIN HR, CALKINS JH: Decreased bio available testos-terone in aging normal and impotent men. J Clin. Endocrin. Met. (1986) 63:1418–1420.
   PubMed Web of Science ®Google Scholar
• KAISER FE, VIOSCA SP, MORLEY JE et al.: Impotence and aging: clinical and hormonal factors. J Amer. Geriatrics Soc. (1988) 36:511–519.
   PubMed Web of Science ®Google Scholar
• VERMEULEN A: Androgens in the aging male. J. Clin.Endocrin. Met. (1991) 73:221–224.
   PubMed Web of Science ®Google Scholar
• WOLDEN-HANSON T, MITTON DR, MCCANTS RL et al.:Daily melatonin administration to middle aged male rats suppresses body weight, intraabdominal adiposity and plasma leptin and insulin independent of food intake and total body fat. Endocrinology (2000) 141:487–497.
   PubMed Web of Science ®Google Scholar
• SHANAHAN TL, CZEISLER CA: light exposure inducesequivalent phase shifts of the endogenous circadian rhythms of circulating plasma melatonin and core body temperature in men. J. Clin. Endocrin. Met. (1991) 73:227–235.
   PubMed Web of Science ®Google Scholar
• •Significance melatonin effects.
   Google Scholar
• ROSENTHAL NE: Plasma melatonin as a measure of the human clock. J. Clin. Endocrin. Met. (1991) 73:225–226.
   PubMed Web of Science ®Google Scholar
• SMITH RG, LEX HT, VAN DER PLOEG et al.: Peptidomi-metic regulation of growth hormone secretion. Endocrine Rev. (1997) 18:621–645.
   Google Scholar
• PARR TB: New technique to elevate of night time. Growth hormone release and a potential growth hormone feedback control loop. Med. Hypotheses (2000) 54:In press.
   Google Scholar
• RATTAN S: Synthesis, modifications and turnover of proteins during aging. Exptl. Gerontology (1996) 31:33–47.
   PubMedGoogle Scholar
• ARVAT E, CAMANNI F, GHIGO E: Age related growth hormone-releasing activity of growth hormone secretagogues in humans. Acta Paediatr. Suppl. (1997) 423:92–96.
   PubMedGoogle Scholar
• SVENSSON J: Growth hormone secretagogues. Exp.Opin. Ther. Patents (2000) 10 (7):1071–1080.
   Web of Science ®Google Scholar
• HARTMAN ML, VELDHUIS JD, THORNER MO: Normal control of growth hormone secretion. (1993) Horm. Res. 40: 37–47.
   Google Scholar
• ••Understanding GH regulation.
   Google Scholar
• SONNTAG WE, LYNCH CD, CEFALU WT et al.: Pleiotropic effects of growth hormone and insulin-like growth factor (IGF)-1 on biological aging: inferences from moderate caloric-restricted animals. J Gerontol. (1999) 54:B521–B538.
   Google Scholar
• VELDHUIS JD, CARLSON ML, JOHNSON ML: The pituitarygland secretes in bursts. Proc. Natl. Acad. Sci. USA (1987) 8 4:7686–7690.
   Google Scholar
• ACHERMANN JC, HINDMARCH PC, ROBINSON IC et al:The relative roles of continuous growth hormone releasing hormone and intermittent somatostatin in growth hormone pulse generation. Clin. Endocrinol. (1999) 51:575–585.
   PubMedGoogle Scholar
• STEPHENS EA, BROWN D, LENG G et al. Computer simulation of a mathematical model of pituitary growth hormone release. J Physiology (1996) 495:7P (ABSTRACT).
   Google Scholar
• COPINSCHI G, ONDERBERGEN AV, BALERIAUX ML et al.:Effects of a 7-day treatment with a novel orally active growth hormone secretagogue MK-677. J. Clin. Endocrin. Met. (1996) 81:2776–2782.
   PubMed Web of Science ®Google Scholar
• TERZOLA M, BOSSONI S, ALT A et al.: Growth hormoneresponses to GH releasing hormone alone or combined with arginine: evidence of enhanced somatostatinergic tone. J Clin. Endocrin. Met. (2000) 85:1310–1315.
   PubMedGoogle Scholar
• COCCHI D, COLONNA V, BAGNASCO D et al.: Izptinregulates GH secretion in the rat by acting on GHRLI and somatostatinergic functions. (1999) J Endocri-nology162:95–99.
   Google Scholar
• CARRO E, SENARIS RM, FROHMAN LA et al.: Role of growth hormone (Gil) releasing hormone and somatostatin on Leptin- induced GH secretion. Neuroendocrinology (2000) 69 3–10.
   Google Scholar
• LUUKKAA V, PERONEN U, HUHTANIEMI I et al.: Inverse correlation between serum testosterone and leptin in men. J. Clin. Endocrin. Met. (1998) 83:3243–3246.
   PubMed Web of Science ®Google Scholar
• HUNTER SK, THOMPSON MW, ADAMS RD: Relationships among age-associated strength changes and physical activity level, limb dominance and muscle group in women. J. Gerontology-Biol. Sci. (2000) 5 5A:B264–B273.
   Google Scholar
• DIEGUEZ C, CARRO E, SEOANE LM et al.: Regulation of somatotroph cell function by the adipose tissue. Int. J. Obes. Relat. Metab. Disord. (2000) 2 (Suppl. 20S100–S103.
   Google Scholar
• SHORT KR, NAIR KS: The effect of age on protein metabolism. Curr. Opin. Clin. Nutr. Met. Care. (2000) 3:39–44.
   PubMedGoogle Scholar
• •The outward and visible effects of ageing.
   Google Scholar
• CAGNNACCI A, SOLDANI R, YEN S: Hypothermic effect of melatonin and nocturnal core body temperature decline are reduced in aged women. J. Appl. Physiol (1995) 78(0:314–317.
   PubMedGoogle Scholar
• ZEITER JM, DANIELS JE, DUFFY JF et al.: Do plasma melatonin concentrations decline with age? Am. J. Med. (1999) 107 (5):432–436.
   Google Scholar
• CHASHI Y, OKAMOTO N, UCHIDA K et al.: Differentialpattern of the circadian rhythm of serum melatonin in young and elderly healthy subjects. Biol. Signals. (1997) 6:301–306.
   PubMedGoogle Scholar
• YU H, BECKEL H: Insulin-like growth factors andcancer. J LA State Med. Soc. (1999) 151(4):218–223.
   PubMedGoogle Scholar
• MARTIN-DU PAN RC: Are hormones of youth carcino-genic. Ann. Endocrin. (Paris) (1999) 60 (5):392–397.
   PubMedGoogle Scholar